Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000007

CEO bought 59,000 shares at an average $0.03 ($1,696)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Collier Alan Brian CEO 2019-01-28 Purchase +1,000 $0.03 $28 20,994,623 D
Collier Alan Brian CEO 2019-01-28 Purchase +1,000 $0.03 $28 20,995,623 D
Collier Alan Brian CEO 2019-01-28 Purchase +1,000 $0.03 $28 20,996,623 D
Collier Alan Brian CEO 2019-01-28 Purchase +5,000 $0.03 $157 21,001,623 D
Collier Alan Brian CEO 2019-01-28 Purchase +10,000 $0.03 $313 21,011,623 D
Collier Alan Brian CEO 2019-01-28 Purchase +10,000 $0.03 $310 21,021,623 D
Collier Alan Brian CEO 2019-01-28 Purchase +2,000 $0.03 $58 21,023,623 D
Collier Alan Brian CEO 2019-01-28 Purchase +2,000 $0.03 $56 21,025,623 D
Collier Alan Brian CEO 2019-01-29 Purchase +5,000 $0.03 $135 21,030,623 D
Collier Alan Brian CEO 2019-01-29 Purchase +5,000 $0.03 $133 21,035,623 D
Collier Alan Brian CEO 2019-01-29 Purchase +5,000 $0.03 $135 21,040,623 D
Collier Alan Brian CEO 2019-01-29 Purchase +5,000 $0.03 $131 21,045,623 D
Collier Alan Brian CEO 2019-01-29 Purchase +5,000 $0.03 $135 21,050,623 D
Collier Alan Brian CEO 2019-01-29 Purchase +1,000 $0.03 $27 21,051,623 D
Collier Alan Brian CEO 2019-01-29 Purchase +1,000 $0.03 $26 21,052,623 D
Open-market purchases · 59,000 sh · avg $0.03 · $1,696
Loading xslF345X03/primary_doc.xml…